Realities of KRAS-mutated non-small cell lung cancer
- PMID: 28490719
- PMCID: PMC5432811
- DOI: 10.3904/kjim.2017.148
Realities of KRAS-mutated non-small cell lung cancer
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Comment on
-
KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer.Korean J Intern Med. 2017 May;32(3):514-522. doi: 10.3904/kjim.2015.299. Epub 2017 Apr 14. Korean J Intern Med. 2017. PMID: 28407465 Free PMC article.
References
-
- Matikas A, Mistriotis D, Georgoulias V, Kotsakis A. Targeting KRAS mutated non-small cell lung cancer: a history of failures and a future of hope for a diverse entity. Crit Rev Oncol Hematol. 2017;110:1–12. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous